Efficacy and safety of erlotinib in elderly patients with non-small-cell lung cancer harboring epidermal growth factor receptor mutations
Not Applicable
Recruiting
- Conditions
- non-small-cell lung cancer
- Registration Number
- JPRN-UMIN000012056
- Lead Sponsor
- Shimane university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
Not provided
Exclusion Criteria
1) EGFR mutation T790M positive 2) Active concomitant malignancy. 3) Interstitial pneumonia or pulmonary fibrosis on chest CT scans 4) Active concomitant malignancy 5) Pregnant or breast-feeding females 6) Inappropriate patients for this study judged by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method